Cargando…

Tackling cardiovascular co-morbidities in HIV-positive patients: who, how and where?

INTRODUCTION: Cardiovascular disease (CVD) is a significant cause of non-AIDS-related morbidity and mortality in HIV-positive individuals [1]. Management of CVD and associated risk factors in HIV are complicated by drug interactions [2]. Optimal management can require specialist input. A previous co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rolls, Sophie, Denneny, Emma, Marcus, Rebecca, O'Connell, Rebecca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2014
Materias:	Poster Sessions – Abstract P193
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225426/ https://www.ncbi.nlm.nih.gov/pubmed/25397471 http://dx.doi.org/10.7448/IAS.17.4.19725

Ejemplares similares

Granulomatose faciale 38 ans après des injections de produits de comblement : rôle précipitant de la COVID-19 et intérêt du méthotrexate
por: Bernigaud, Charlotte, et al.
Publicado: (2021)

Sexual attitudes of Turkish population during the COVID-19 outbreak
por: Sahin, O., et al.
Publicado: (2022)

Nanoencapsulation as a novel delivery approach for therapeutic applications of gla-rich protein (GRP)
por: Araújo, Nuna, et al.
Publicado: (2021)

Ongoing epidemic of lymphogranuloma venereum in HIV-positive men who have sex with men: how symptoms should guide treatment
por: Mohrmann, Gerrit, et al.
Publicado: (2014)

Socio-economic factors and virological suppression among people diagnosed with HIV in the United Kingdom: results from the ASTRA study
por: Burch, Lisa, et al.
Publicado: (2014)

Co-infections and co-morbidities among injecting drug users versus sexually infected patients in Bucharest
por: Manea, Eliza, et al.
Publicado: (2014)

Morbidity and mortality in HIV-exposed under-five children in a rural Malawi setting: a cohort study
por: Divala, Oscar, et al.
Publicado: (2014)

Who gets single tablet regimens (STR), and why?
por: Tarrier, Laura, et al.
Publicado: (2014)

CD4/CD8 ratio is not predictive of multi-morbidity prevalence in HIV-infected patients but identify patients with higher CVD risk
por: Menozzi, Marianna, et al.
Publicado: (2014)

Lipid-lowering agents for dyslipidemia in patients who were infected with HIV in Taoyuan, Taiwan
por: Cheng, Shu-Hsing, et al.
Publicado: (2014)

ART management in children perinatally infected with HIV from mothers who experience behavioural changes in Romania
por: Märdärescu, Mariana, et al.
Publicado: (2014)

Should screening for Chlamydia trachomatis and Neisseria gonorrhoeae in HIV-men who have sex with men be recommended?
por: Pérez-Hernández, Isabel, et al.
Publicado: (2014)

Should we offer routine hepatitis C antibody testing in men who have sex with men?
por: Ward, Christopher, et al.
Publicado: (2014)

Switching from ritonavir to cobicistat in HIV patients with renal impairment who are virologically suppressed on a protease inhibitor
por: Fisher, Martin, et al.
Publicado: (2014)

Mediterranean diet: the impact on cardiovascular risk and metabolic syndrome in HIV patients, in Lisbon, Portugal
por: Policarpo, Sara, et al.
Publicado: (2014)

Cardiovascular markers of inflammation and serum lipid levels in HIV-infected patients with undetectable viraemia
por: Viskovic, Klaudija, et al.
Publicado: (2014)

Estimation of the true incidence of lactic acidosis within the Lighthouse Clinic cohort, and the likely magnitude of missed diagnoses in the region
por: Speight, Colin, et al.
Publicado: (2014)

Acceptability of PrEP among HIV negative Portuguese men who have sex with men that attended 2014 Lisbon pride fair
por: Miguel Rocha, Luís, et al.
Publicado: (2014)

Prevalence of anal human papillomavirus infection and cytologic abnormalities among HIV-infected and HIV-uninfected men who have sex with men
por: Latini, Alessandra, et al.
Publicado: (2014)

The cost-effectiveness in the use of HIV counselling and testing-mobile outreaches in reaching men who have sex with men (MSM) in northern Nigeria
por: Ifekandu, Chiedu, et al.
Publicado: (2014)

The potential impact of new national guidance on primary prevention of cardiovascular disease in people living with HIV
por: Ahmed, Nadia, et al.
Publicado: (2014)

Effect of hyperbilirubinaemia on neurocognitive, renal, bone and cardiovascular markers in HIV infection treated with boosted protease inhibitors
por: Barber, Tristan J, et al.
Publicado: (2014)

The efficacy, pharmacokinetics, safety and cardiovascular risks of switching nevirapine to rilpivirine in HIV-1 patients: the RPV switch study
por: Rokx, Casper, et al.
Publicado: (2014)

Effectiveness of a team intervention in reducing modifiable cardiovascular disease risk in HIV-infected subjects on antiretroviral therapy
por: Bloch, Mark, et al.
Publicado: (2014)

Impact of NRTI backbone on renal, bone and cardiovascular markers in HIV-infected individuals receiving a boosted protease inhibitor
por: Barber, Tristan, et al.
Publicado: (2014)

Prevalence and concordance of high cardiovascular disease scores in HIV/AIDS patients from Croatia and Serbia with four international algorithms
por: Begovac, Josip, et al.
Publicado: (2014)

Sexual behaviour, recreational drug use and hepatitis C co-infection in HIV-diagnosed men who have sex with men in the United Kingdom: results from the ASTRA study
por: Daskalopoulou, Marina, et al.
Publicado: (2014)

Rates of cardiovascular events and deaths are associated with advanced stages of HIV-infection: results of the HIV HEART study 7, 5 year follow-up
por: Esser, Stefan, et al.
Publicado: (2014)

Evolution of Framingham cardiovascular risk score in HIV-infected patients initiating EFV- and LPV/r-based HAART in a Latin American cohort
por: Cecchini, Diego, et al.
Publicado: (2014)

Effectiveness of the prevention of mother-to-child transmission of HIV protocol applied at Saint Camille Medical Centre in Ouagadougou, Burkina Faso
por: Theophile Soubeiga, Serge, et al.
Publicado: (2014)

TACKLING THE OPIOID EPIDEMIC: A STATE-WIDE INITIATIVE TO DECREASE OPIOID PRESCRIBING
por: Chahal, Jasleen K, et al.
Publicado: (2019)

Targeted destruction of HIV-positive cells
por: Sharma, Jyoti R, et al.
Publicado: (2014)

Predictors of emphysema progression in HIV-positive patients
por: Guaraldi, Giovanni, et al.
Publicado: (2014)

O.1.1-2 How can the sport sector help tackle mental health problems?
por: van Stam, Wikke
Publicado: (2023)

The effect of tenofovir on renal function in HIV-positive pregnant women
por: Flanagan, Stuart, et al.
Publicado: (2014)

Liver fibrosis is associated with cognitive impairment in HIV-positive patients
por: Ciccarelli, Nicoletta, et al.
Publicado: (2014)

Depression in HIV-positive women is associated with changes in antiretroviral treatment regimens
por: Philippe Küpper-Tetzel, Claus, et al.
Publicado: (2014)

HIV positive asylum seekers receiving the order to leave the Belgian territory
por: Demeester, Remy, et al.
Publicado: (2014)

Overall and cause-specific mortality in HIV-positive subjects compared to the general population
por: Alejos, Belen, et al.
Publicado: (2014)

The prevalence and predictive value of dipstick urine protein in HIV-positive persons in Europe
por: Mocroft, Amanda, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_pg624fi0en8j9n7ogkqm4da0k2